CLINICAL TRIALS PROFILE FOR MIDODRINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for MIDODRINE HYDROCHLORIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00004268 ↗ | Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension | Completed | Roberts Pharmaceutical | Phase 2 | 2001-04-01 | OBJECTIVES: I. Study further the safety and efficacy of the alpha-receptor agonist midodrine in patients with neurogenic orthostatic hypotension. II. Assess the quality of life in these patients with this treatment regimen. |
NCT00004268 ↗ | Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension | Completed | National Center for Research Resources (NCRR) | Phase 2 | 2001-04-01 | OBJECTIVES: I. Study further the safety and efficacy of the alpha-receptor agonist midodrine in patients with neurogenic orthostatic hypotension. II. Assess the quality of life in these patients with this treatment regimen. |
NCT00004479 ↗ | Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope | Completed | Icahn School of Medicine at Mount Sinai | N/A | 1999-03-01 | OBJECTIVES: Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing neurally mediated syncope. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MIDODRINE HYDROCHLORIDE
Condition Name
Clinical Trial Locations for MIDODRINE HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for MIDODRINE HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for MIDODRINE HYDROCHLORIDE
Sponsor Name